Detalhe da pesquisa
1.
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.
Gut
; 71(5): 938-949, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34059508
2.
APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
Ann Surg
; 272(6): 1080-1085, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379870
3.
Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.
Ann Surg
; 269(5): 917-923, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28767562
4.
Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.
Ann Surg
; 267(3): 514-520, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28002060
5.
Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
Ann Surg Oncol
; 25(1): 179-187, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29071660
6.
Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.
J Vasc Interv Radiol
; 29(3): 395-403.e1, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29395898
7.
RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
Ann Surg Oncol
; 23(8): 2635-43, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27016292
8.
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer.
Cancer Discov
; 14(6): 982-993, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587856
9.
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.
Clin Cancer Res
; 30(10): 2121-2139, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416404
10.
RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Ann Surg
; 258(4): 619-26; discussion 626-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24018645
11.
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers.
J Hematol Oncol
; 15(1): 23, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260176
12.
Colorectal Liver Micrometastases: Association with RAS/TP53 Co-Mutation and Prognosis after Surgery.
J Am Coll Surg
; 235(1): 8-16, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703957
13.
A path to translation: How 3D patient tumor avatars enable next generation precision oncology.
Cancer Cell
; 40(12): 1448-1453, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270276
14.
Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases.
J Am Coll Surg
; 233(1): 82-89.e1, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667566
15.
From multidisciplinary to personalized treatment of colorectal liver metastases: 4 reasons to consider RAS.
Cancer
; 119(23): 4083-5, 2013 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105015
16.
SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
Eur J Surg Oncol
; 44(5): 684-692, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551247
17.
RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases.
J Gastrointest Surg
; 21(1): 68-77, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27334313
18.
Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection.
J Gastrointest Surg
; 21(4): 628-635, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27882510
19.
Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection.
Surgery
; 161(2): 332-340, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27592215
20.
Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis.
Adv Radiat Oncol
; 2(3): 455-464, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29114614